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The ratio of peak hyperemiclhasal mean coronary flow 
velocity, an index of coronary vasodilator reserve, imme- 
diately after coronary angioplasty normalizes in <SO% of 
patients. To evaluate other indexes of coronary vasodilator 
capacity, both intracoronary arterial velocity and cardiac 
venous efflux were measured at rest and during vasodilator- 
induced coronary hyperemia (intracoronary nitroglycerin 
and papaverine) before and after angioplasty in 27 patients; 
17 patients had measurements of intracoronary velocity 
alone and 10 had thermodilution measurements of great 
cardiac vein flow. Coronary flow velocity responses were 
also measured in 6 angiographically normal segments in 
patients undergoing angioplasty and in 10 normal left 
coronary artery segments in patients with normal coronary 
arteries or isolated right coronary artery disease. 
Despite significant angiographic (72 f 12 to 23 f 11% 
diameter narrowing) and hemodynamic (49 +- 12 to 19 + 12 
mm Hg aortocoronary gradient) improvement, coronary 
vasodilator reserve ratios for both arterial velocity and 
venous flow after angioplasty were only minimally affected. 
Angioplasty did not significantly increase rest coronary vein 
Angiographic determination of coronary artery narrowing 
and intraluminal dimensions do not always permit accurate 
assessment of the physiologic changes in coronary blood 
flow (l-6). Immediately after percutaneous transluminal 
coronary angioplasty, angiographic improvement may be 
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flow or artery flow velocities, but did result in significantly 
higher papaverine responses after angioplasty. Mean and 
phasic coronary velocity, diastolic coronary flow velocity 
integral and measured great cardiac vein flow ratios were 
significantly lower when compared with those in 16 angio- 
graphically normal coronary artery segments. 
These data indicate that maximal hyperemic coronary 
flow velocity is increased after angioplasty, but the reserve 
ratios, calculated by any of several flow velocity indexes, 
remain minimally improved. Angiographic correlations 
(percent coronary diameter, absolute diameter or cross- 
sectional area) with variables of coronary blood flow or 
velocity suggest that no single variable is useful in assessing 
angioplasty results. However, postangioplasty arterial 
mean velocity and diastolic Bow velocity integral are nearly 
normalized in most patients, whereas relative changes 
remain attenuated. These findings are important in studies 
assessing coronary vasomotor responses in patients with 
atherosclerotic coronary disease, especially after angio- 
plasty. 
(J Am Co11 Cardiol1989;13:860-72) 
obscured by arterial dissection, thrombus or a hazy, dis- 
torted radiographic appearance. Assessment of coronary 
blood flow responses to vasodilators has been proposed as a 
physiologic method to identify critical coronary lesions 
(1,7,8) and as a measure of an angiographically successful 
coronary dilation or surgical revascularization (9,lO). How- 
ever, several investigators (11-14) report that coronary flow 
reserve (peak hyperemic flow/rest flow ratio) remains de- 
pressed in approximately half of all patients despite angio- 
graphic and hemodynamic improvement in the epicardial 
artery. Several of these investigators have observed that 
although coronary reserve, as assessed by digital radio- 
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graphic techniques (12,13) or direct measurement of coro- 
nary artery velocity (11) after angioplasty, may not improve 
immediately, the return of normal coronary reserve re- 
sponses may be expected in most patients months later (11). 
These findings are consistent with recent reports (15-17) of 
abnormal vasomotor responses, possibly related to impaired 
endothelial function, in patients with atherosclerotic coro- 
nary artery disease. In addition, factors other than improve- 
ment in arterial luminal dimensions, such as sudden in- 
creases in pressure and how. may subject the distal. 
chronically ischemic coronary vascular bed to a new envi- 
ronment, temporarily altering vasodilator response after 
epicardial dilation (18). It can be postulated that the athero- 
sclerotic coronary vasodilator capacity in humans, despite 
coronary epicardial artery luminal enlargement, remains 
impaired. 
Table 1. Clinical and Left Ventriculographic Data in 34 Patients 
Pt. No. 
.4ge (yr) LVEF Study 
& Gender (2) WM Segment 
Group 1 Angioplasty (arterial) 
I 6lF .AH LAD 
1 5lM 60 .4H LAD 
3 59F 43 ‘AH LAD 
4 65F 47 IA LAD 
5 36M 60 N LAD 
6 40M 67 N LAD 
I 40M -59 ‘AH LAD 
8 45F 62 N LAD 
9 40F 85 IH LCX 
I 0 59M 73 N LAD 
II 63F 75 N LAD 
II 49M x0 N LAD 
13 6SM 61 LH LCX 
14 68M 68 AH LAD 
1.i 79F 15 N LAD 
I6 77M 69 N LAD 
17 53F 67 AH LAD 
Mean f SD 56i I? 65 2 II 
Group II Angtoplasty (venous) 
In this study we examined indexes of coronary artery 
flow velocity (inflow) and, by separate but correlative tech- 
nique. venous (outflow) coronary circulatory responses to 
clinically used doses of intracoronary nitroglycerin (subma- 
ximal vasodilator) and papaverine (maximal vasodilator) 
before and after coronary artery balloon dilation. Our aim 
was to address the following issues: 1) to what degree does 
acute reduction of epicardial obstruction affect indexes of 
coronary flow and velocity relative to angiographically nor- 
mal coronary artery segments. and 2) how do coronary 
artery velocity indexes and coronary venous efflux re- 
sponses correlate with angiographic measurements of coro- 
nary stenoses before and after angioplasty’? 
Methods 
Study patients (Table 1). The study group consisted of 27 
patients (Group I, arterial responses; Group II. venous 
responses) undergoing angioplasty for routine clinical indi- 
cations and 7 patients (Group III) with a normal left coronary 
artery system undergoing routine diagnostic angiography. 
All Group I and II patients had at least one significant left 
coronary artery stenosis (>60% luminal diameter narrowing) 
determined by visual estimation of two experienced coro- 
nary angiographers. Left anterior descending coronary ar- 
tery angioplasty was performed in 15 of the 17 patients in 
Group I and all 10 patients in Group II. Patients 9 and 13 in 
Group I had circumflex artery angioplasty. Three patients 
had other coronary artery disease, two of a small nondomi- 
nant occluded right coronary artery and one of a circumflex 
marginal branch. Objective evidence of myocardial ischemia 
was present by stress electrocardiography with or without 
positive thallium-201 scintigraphy. In 6 of the 27 patients 
undergoing angioplasty. coronary flow velocity responses 
were measured in a normal left coronary artery (usually the 
circumflex) segment. Patients with acute unstable angina 
(<24 h), angiographic evidence of intracoronary thrombus, 
acute myocardial infarction (~72 h). unsuitable angioplasty 
I 79M 62 AH LAD 
2 65M 69 N LAD 
3 44M - .AH LAD 
4 75M 8X N LAD 
5 6hM 59 AH LAD 
6 55F - N LAD 
1 4OM 81 N LAD 
8 62M - N LAD 
9 ZXM 6X N LAD 
IO 53M 50 IH LAD 
Mean i SD 60 + I I 682 I2 
Croup 111 (patients with normal arterial segments) 
II* 63F 75 LCX 
9* 40F 85 LAD 
I 39M 59 LAD 
, 54M 71 LAD 
2a 71 LCX 
3 4XM 63 LAD 
3a - - LCX 
4 67M 66 LAD 
la - LCX 
5 49M 60 LAD 
13” 65M 61 LAD 
IO 59M 73 LAD 
l Od* - - LCX 
6 69M 68 LAD 
15% 79F IS LCX 
7 63M 72 LAD 
“Normal arterial segment from corresponding patient m Group 1. AH = 
anterior hypokinesia; F = female; IA = inferior akinesia; IH = inferior 
hypokinesia: LAD = left anterior descending coronary artery: LCx = left 
circumflex coronary artery: LVEF = left ventricular ejection fraction 
(30” right anterior oblique projection): M = male; N = normal; Pt. = patient: 
WM = left ventricular wall motion abnormality: - = ejection fraction not 
computed. 
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Table 2. Study Protocol for Assessments of Coronary Vasodilator Responses Before and After Coronary Angioplasty 
Angioplasty patients 
Group I: arterial velocity 
Group II: venous flow 
Normal segments 
Angioplasty patients (Group I) 
Group Me normal patients 
No. of 
Patients 
17 
IO 
6 
IO 
(1) 
Control 
t 
t 
t 
t 
(2) 
PAPiNTG 
t 
t 
t* 
t* 
(3) 
Control 
t 
t 
(4) 
NTGlPAP 
t 
t 
Angioplasty 
Repeat Steps 
I to4 
*Papaverine only (no administration of nitroglycerin). NTG = nitroglycerin: PAP = papaverine. 
anatomy (for example, left main coronary artery involve- 
ment, severely complex or long lesions), valvular heart 
disease, congestive heart failure, left ventricular ejection 
fraction ~50% or more than mild left ventricular wall motion 
abnormalities were excluded. Patients with angiographic 
collateral vessels to the perfusion field under study or distal 
lesions were not included. The research protocol was ap- 
proved by the Human Subjects Committee of the Institu- 
tional Review Board at St. Louis University Hospital. All 
patients gave informed written consent in accordance with 
guidelines established by the Human Subjects Committee. 
For patients undergoing angioplasty, beta-adrenergic 
blocking drugs, calcium channel antagonists and long-acting 
nitrates were not withheld for this study. All patients re- 
ceived 325 mg of aspirin orally the night before angioplasty 
and 10,000 U of heparin intravenously after insertion of the 
angioplasty guiding catheter, with a 1,000 U/h continuous 
infusion. Diphenhydramine (50 mg) and meperidine (25 mg) 
were given as routine precatheterization medications, with 
5,000 U of heparin intravenously at the initiation of the 
procedure in all patients. No sublingual or intracoronary 
medications were given until the initiation of the study. 
Sublingual or oral calcium channel blockers were not given 
during angioplasty. 
Experimental Protocol 
In patients undergoing angioplasty, the study protocol 
was designed to measure vasodilator responses to both 
papaverine and nitroglycerin before and after coronary 
angioplasty. In normal artery segments, only papaverine 
responses were obtained (Table 2). 
Coronary artery velocity measurements. Intracoronary 
artery flow velocity was measured with use of a 2SF 
Doppler catheter system (Millar instruments) with a 20 MHz 
pulsed Doppler crystal, as described by Wilson et al. (19) 
and others (20). After an 8F left guiding catheter (USCI, 
Bard, Inc. or Shiley, Inc.) was positioned in the left coronary 
ostium, an 0.014 in., 300 cm exchange angioplasty guide wire 
was positioned well beyond the coronary lesion. The Dopp- 
ler catheter was advanced over the guide wire and positioned 
immediately proximal to the stenosis or within a proximal 
normal segment beyond any large branches. This location 
was recorded on videotape for catheter replacement after 
angioplasty. The Doppler velocity and hemodynamic signals 
were displayed and recorded on a photographic multichannel 
oscillographic recorder (model VR12, Electronics for Medi- 
cine, Pleasantville, New York). Mean and phasic Doppler 
velocity signals were calibrated before catheter placement 
from an internally set arbitrary 0 to 100 cm/s, representing 
full scale deflection. 
For patients undergoing angioplasty, after stable baseline 
coronary velocity signals and guiding catheter pressure 
(nondamped) were obtained, 200 pg of nitroglycerin was 
injected into the left coronary artery as a bolus over 1 to 2 s 
and velocity signals and hemodynamic data were recorded 
through the peak hyperemic period and for 60 to 90 s later. 
After a 3 min equilibration period, another set of baseline 
measurements was obtained, immediately followed by intra- 
coronary injection of 10 mg of papaverine and continuous 
recording through the peak hyperemic response for at least 
90 s thereafter. A second, duplicate 10 to 12 mg papaverine 
injection after a 3 min equilibration period was also per- 
formed. The order of nitroglycerin and papaverine adminis- 
tration was reversed in six patients. 
Coronary vein flow measurements. In 10 patients under- 
going angioplasty, a triple thermistor coronary sinus thermo- 
dilution catheter (Webster Laboratories) was inserted per- 
cutaneously or by small left brachial vein cutdown and 
positioned in the great cardiac vein before baseline measure- 
ments; 2 ml of contrast medium verified the position of the 
distal thermistor. After obtaining stable great cardiac vein 
blood flow signals, intracoronary administration of nitroglyc- 
erin and papaverine was performed identically as for the 
coronary artery velocity measurements. The order of drug 
administration was reversed in four patients in this group. 
Angioplasty method and postangioplasty coronary hemo- 
dynamic data. After the preangioplasty coronary vasodila- 
tor measurements were obtained in Group I, the Doppler 
catheter was exchanged for an angioplasty catheter (in 
Group II, the angioplasty catheter and guide wire system 
were then introduced), and the lesion was crossed with an 
appropriate-sized (2.5 to 3.5 mm) angioplasty balloon cath- 
eter. In 23 patients, satisfactory translesional coronary gra- 
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Figure 1. Intracoronary Doppler velocity signal. The 
diastolic flow integral area used to estimate volumetric 
2DOmmHg 1 OOcmlsec 
-Y .___ 
flow is represented by the area (I,) bounded by the / 
aortic (AO) dicrotic notch to the systolic upstroke. 
ACC, = mean acceleration; ECG = electrocardiogram: 
mVEL = mean velocity signal (scale 0 to 100 cm/s): 
pVEL = phasic velocity signal: I,,z = half diastolic flow 
velocity integral; I,,, = one-third of diastolic flow veloc- 
ity integral; T, = time to peak phasic velocity; 
T, = total diastolic time; V, = peak phasic velocity. 
dients were obtained. When feasible during balloon occlu- 
sion, coronary occlusion wedge pressure was measured to 
identify the extent of acutely recruitable collateral vessels 
(21,22). Several balloon inflations (usually three to five with 
6 to IO atm for 45 to 90 s) were performed and the dilations 
concluded when the angiographic and hemodynamic results 
appeared adequate as previously reported from our labora- 
tory (23). The final aortocoronary artery gradient was re- 
corded, the angioplasty catheter withdrawn and. in Group I 
patients, replaced with the intracoronary Doppler catheter, 
with the position matched to the preangioplasty location 
relative to the lesion. Identical measurements for nitroglyc- 
erin and papaverine vasodilator responses were obtained as 
in the preangioplasty data collection periods no sooner than 
15 min after the last balloon inflation. Because of the clinical 
nature of human studies of this type, no patient had mea- 
surements made later than 45 min after the last inflation. 
Final angiographic images for measurements were obtained 
with guide wires removed. 
To assess coronary vasodilator reserve in angiographi- 
tally normal left coronary artery branches, intracoronary 
papaverine hyperemia was measured in 16 coronary seg- 
ments; 6 in normal segments in the angioplasty group, 7 in 
left anterior descending segments and 3 in circumflex seg- 
ments in the seven patients in Group III (normal left coro- 
nary system). 
Angiographic measurements. After the study, the devel- 
oped cineangiograms were projected on a General Electric 
CAP-12 projector. Digital computer-assisted calipers (Sand- 
hill Scientific, Inc., Littleton, Colorado) were used to mea- 
sure the angiographically normal artery segment proximal to 
the stenosis, the diameter stenosis, the balloon diameter at 
full inflation and the guiding catheter diameter to provide a 
scale factor for absolute dimension calculations. The percent 
diameter stenosis was the average of two orthogonal projec- 
tions. when available, or the most severe narrowing of 
several nonorthogonal angiographic projections. The abso- 
lute stenosis diameter (in mm) was measured and used to 
compute an approximate cross-sectional area (tid/2])‘, 
where d = diameter of the stenosis, assuming a symmetric 
geometry of the stenosis and minimal effect on the rest 
diameter of the vessel by contrast medium or vasodilators at 
the time of velocity measurement. Overestimation of vaso- 
dilator reserve of approximately 16% with papaverine- 
induced vessel diameter enlargement has been reported (24). 
The length of the lesion was ~0.5 cm in 25 patients under- 
going angioplasty. 
Coronary velocity signal analysis. Coronary artery veloc- 
ity signals, both phasic and mean, were recorded at a paper 
speed of both IO and 100 mm/s and digitized on an off-line 
microcomputer system. When suitable (30 segments), the 
diastolic flow velocity integral I, or DFV; (area from the 
aortic dicrotic notch to the systolic aortic upstroke under the 
diastolic velocity signal) (Fig. 1) was computed and used to 
calculate absolute flow from the product (flow velocity 
integral times heart rate times cross-sectional area) of the 
normal proximal vessel segment (25,261. In addition, the 
total time of diastolic flow velocity (TE), time to peak 
maximal velocity (T,) and the first one-third (1,/J and 
one-half (I,,?) of total diastolic flow velocity integral were 
measured. A coronary artery resistance index (CVR,) was 
computed as the quotient of mean arterial pressure and mean 
coronary velocity. 
Coronary vein thermodilution signal analysis. Great car- 
diac vein flow was calculated by the methods of Ganz et al. 
(27) and Pepine et al. (28). Great cardiac vein signals 
reflected the venous efflux from the left ventricular region 
supplied predominantly by the left anterior descending cor- 
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BEFORE PICA 
baseline papaverine 
A AFTER PTCA 
onary artery. Each coronary thermodilution value was the 
average of five calculations made over a 5 s period (imme- 
diately before vasodilator administration and at peak signal 
deflection) by off-line digitizing of the hard copy recording. 
Coronary vein resistance was calculated as a quotient of 
mean arterial pressure and great cardiac vein or total coro- 
nary sinus flow. 
Coronary vasodilator reserve ratios. Coronary reserve 
ratios were computed as the peak hyperemic flow/basal flow 
for both the great cardiac vein flow, mean and peak phasic 
coronary artery velocity response as well as diastolic flow 
velocity integral. A percent increase from baseline value was 
also computed as ([peak - basal]/basal) times 100. Figure 2A 
shows data records for a patient before and after angio- 
plasty. Figure 2B shows typical tracings for velocity re- 
sponses in a normal coronary artery segment. 
Duplicate coronary responses to intracoronary nitroglyc- 
erin, normal saline solution and papaverine were obtained in 
16 patients undergoing angioplasty. The reproducibility of 
coronary vein and artery velocity flow values over the 
measurement periods was within + 10%. 
Statistical methods. Each patient served as his or her own 
control. Data were analyzed by one-way analysis of vari- 
ance. Stepwise linear regression was used for correlation 
A0 
0 , 
B 
Figure 2. A, Representative data recordings before and after coro- 
nary angioplasty (PTCA). A0 = aortic pressure; mVEL = mean 
intracoronary Doppler velocity (scale 0 to 100 cm/s); pVEL = 
phasic velocity. Numbers over mean velocity are used to compute 
the coronary reserve ratio. Before angioplasty the reserve ratio is 
25115 = 1.67: after angioplasty it is 32115 = 2.13. B, Typical normal 
hyperemic response. Coronary reserve ratio is 40112 = 3.33. Abbre- 
viations as in Figure I. 
coefficients for coronary reserve ratios with angiographic 
data. In addition, polynomial regression analysis was applied 
to identify whether higher correlation coefficients could be 
obtained by nonlinear regression analysis. When analysis of 
variance was significant, comparisons of the mean values 
were made with use of Duncan’s multiple range F statistic 
(29) and, when appropriate, paired and nonpaired Students t 
tests were performed. Statistically significant probability (p) 
values were accepted at p < 0.05. Results are expressed as 
mean values 2 SD unless otherwise indicated. 
Results 
Systemic hemodynamic data responses to vasodilators 
(Table 3). Mean arterial pressure was higher for Group I1 
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(venous responses) than Group 1 (arterial responses) both 
before and after angioplasty (105 -C I1 versus 90 ? 12 mm 
Hg, p < 0.05 before: 104 i- 16 versus 8X +- 10 mm Hg, p < 
0.05 after) and was significantly reduced by nitroglycerin in 
Group II. Relative (% 1) reductions in mean arterial pressure 
during intracoronary vasodilator administration were similar 
before and after angioplasty (-10 ? 13, - 16 i 7% for 
nitroglycerin: -6 ?I X. -2 i- 8% for papaverine. respec- 
tively). There were no differences between groups with 
respect to heart rate or heart rate-systolic pressure product. 
Hemodynamic responses for normal patients (Group III) 
were not statistically different from angioplasty patient 
groups (Groups I and II). 
Coronary angiographic measurements (Table 4). Angio- 
plasty significantly increased absolute angiographic luminal 
diameter narrowing and computed stenosis area in both 
Groups I and II. Comparable angiogrdphic measurements of 
the normal compared with postangioplasty arterial segments 
were present among patients undergoing angioplasty. The 
percent stenosis diameter narrowing was similar for both 
groups. 
Coronary artery and vein flow responses before and after 
angioplasty (Table 5). As in previous studies with intracoro- 
nary nitroglycerin (30). the peak coronary vasodilator effect 
occurred between I5 and 40 s and lasted approximately 2 to 3 
min. Peak hyperemic papaverine responses. similar to those 
in previously published studies (24.3 I .32). occurred between 
20 and 35 s, with return to baseline within 120 s. Significantly 
greater increases in the mean and phasic arterial velocities (52 
2 57 versus 114 IL 937~. respectively. p < 0.05) and computed 
Doppler flow. as well as total and regional coronary vein flow 
(35 !: 23 versus 75 + 3%. p < 0.05) were obtained with 
papaverine compared with nitroglycerin. However. the 
changes in flow normalized for pressure response (that is. 
great vein resistance and coronary artery resistance index 
[CVR,]) were similar. The papaverine vasodilator responses 
were similar whether measured before or after intracoronary 
nitroglycerin. 
Mean and phasic peak velocity after papaverine increased 
significantly after angioplasty (mean velocity 20.5 I 13.6 to 
32.9 + 1 I. I cm/s; peak phasic velocity 30.8 t 16.7 to 46.5 ? 
13.0 cm/\. both p < 0.05 versus before angioplasty). These 
postangioplasty responses were of similar magnitude to those 
in normal segments. However, because of increases in imme- 
diate (~45 min) postangioplasty basal values. ratios of peak/ 
basal flow after angioplasty did not increase. with the percent 
change remaining significantly less than in normal segments 
(mean velocity IS7 t 105 versus 235 -C 116%. p < 0.05, 
postangioplasty versus normal segments). Similar response 
patterns were present for diastolic flow velocity integral, peak 
phasic velocity. coronary artery resistance index Doppler- 
derived flow and measured great cardiac vein flow. 
There mere no significant differences with respect to total 
time of diastolic flow velocity (0.50 t- 0. IO s), time to peak 
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Table 4. Coronary Angiographic Measurements Before (Pre) and After (Post) 
Coronary Angioplasty 
Proximal Normal 
Arterial Segment 
Stenosis Diameter (mm) 
Pre Post 
Stenosis Area (mm’) 
Pre Post 
Diameter (mm) Angioplasty Angioplasty Angioplasty Angioplasty 
Group I 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
I1 
12 
I3 
I4 
15 
16 
I7 
Mean C SD 
Group I1 
1 
2 
3 
4 
5 
6 
1 
8 
9 
10 
Mean f SD 
3.35 I.31 2.65 1.34 5.50 
2.60 0.60 2.50 0.28 4.89 
2.30 0.48 1.93 0.18 2.93 
2.60 0.55 I .98 0.23 3.07 
2.80 0.50 2.32 0.20 4.24 
3.40 0.92 3.13 0.66 7.68 
2.90 1.25 2.29 1.22 4.12 
2.50 0.68 2.00 0.36 3.14 
2.38 0.24 1.76 0.04 2.44 
2.12 0.63 2.01 0.31 3.18 
2.33 0.61 2.19 0.29 3.71 
2.98 1.25 2.68 1.23 5.65 
2.50 0.48 I .98 0.18 3.06 
2.40 0.48 1.56 0.18 1.91 
2.50 0.83 2.10 0.53 3.46 
2.70 0.14 1.08 0.01 0.92 
2.95 0.03 2.07 0.01 3.35 
2.71 t 0.32 0.70 ? 0.35 2.17 2 0.47* 0.48 ? 0.44 3.87 ? 1.60* 
3.30 0.59 2.38 0.27 4.45 
3.10 0.84 2.14 0.55 3.60 
2.10 0.61 I.91 0.29 2.81 
3.30 0.59 2.44 0.27 4.68 
3.20 0.48 2.56 0.18 5.15 
3.00 0.60 2.28 0.28 4.08 
3.80 0.95 2.39 0.71 4.49 
3.00 0.27 2.64 0.06 5.41 
3.40 I .02 3.06 0.82 7.35 
2.80 0.98 2.41 0.75 4.56 
3.10 ? 0.42 0.69 ? 0.23 2.42 + 0.29* 0.42 ? 0.25 4.61 ? 1.14* 
*p < 0.01 versus before angioplasty. Area = computed cross-sectional area of stenosis based on stenosis 
diameter (in mm); arterial diameter = coronary arterial diameter of proximal normal segment by computer-assisted 
caliper measurements; SD = standard deviation. 
phasic velocity (0.16 2 0.08 s), first one-third diastolic flow 
velocity integral (36 + 5%) and first one-half diastolic flow 
velocity integral (57 + 5%) among pre- and postangioplasty 
or normal segment responses. 
Coronary hemodynamics and vasodilator reserve ratios 
before and after angioplasty (Table 6). The initial translesion- 
al gradients, coronary occlusion wedge pressures and 
postangioplasty translesional gradients were similar for both 
groups. Arterial mean velocity coronary reserve ratio for 
nitroglycerin was unchanged after angioplasty (1.52 2 0.57 
to 1.57 t 0.67); for papaverine, it was 2.14 t 0.93 before and 
2.57 _’ 1.05 after angioplasty (both p = NS). In 16 normal 
arterial segments, th$ average coronary reserve ratio was 
3.35 ? 1.16, which was significantly greater than the 
postangioplasty papaverine response of 2.57 t 1.05 (p 5 
0.01). 
Figure 3 displays the individual coronary reserve ratios 
for Group I before and after angioplasty for papaverine 
and normal papaverine responses in our laboratory. The 
normal arterial segment reserve ratio in patients with no 
left coronary disease (Group III, n = 10, 3.64 + 0.69) was 
similar to normal segment ratio in those patients under- 
going angioplasty in another vessel (n = 6, 3.10 k 1.43, p = 
NS). 
For the coronary vein responses, nitroglycerin did not 
increase the coronary reserve ratio after angioplasty (1.35 2 
0.23 before 1.38 k 0.22 after angioplasty). Coronary vein 
reserve ratio after papaverine decreased from 1.75 t 0.35 
before to 1.68 i- 0.35 after angioplasty (p = NS). The 
coronary reserve ratio after angioplasty was higher when 
comparing arterial with venous flow responses (2.57 k 1.05 
versus 1.68 k 0.35, p < 0.05). Figure 4 shows coronary 
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Table 5. Coronary Artery Velocity and Vein Flow Responses to Intracoronary Nitroglycerin and Papaverine Before (Pre) and After 
(Post) Coronarv Angioplasty 
Angioplasty C N C P r/r 1 N 7r .!I P 
Mean VEL 
Pre 
Port 
Normal 
Peak phasic VEL 
Pre 
Post 
Normal 
DFV, 
Pre 
Post 
Normal 
mACC 
Pre 
Post 
Normal 
CVR, 
Pre 
Post 
Normal 
DOP flow 
PI-e 
Post 
Normal 
GVF 
Pre 
Post 
GVR 
Pre 
POTI 
CSF 
Pre 
Post 
CSR 
Pre 
Post 
11.6 + x.2 
19.1 ? II.5 
17.7 t 10.7 
29.8 ? 15.6: 
7.7 i 3.5 
12.0 -t 4.x 
172 2 I03 
301 ? II9 
21 k 41 
Ii7 
- 
289 t 120 
455 + 179 
_ 
9s ir 25 
II4 ? 24 
I.24 ? 0.66 
0.96 ? 0.31 
163 ? 48 
183 + 53 
0.69 5 0.23 
0.60 ? 0.15 
17.1 + 12.3 
26.3 f 13.07 
25.9 ? 14.9 
43.1 i 11.9+ 
- 
10.6 + 3.8 
IS.1 + 6.2 
223 i- 140 
431 i- 312 
16 ? 37 
4+3 
449 2 209 
615 ? 146 
- 
I30 r 41 
I54 lr 27 
0.80 i 0.47 
0.62 + 0.23 
I98 r 42 
777 __- + 45 - 
0.46 2 0.09: 
0.42 ? 0.10 
10.2 f 6.4 
15.4 I? 9.4 
10.1 ? 4.5 
15.5 % x.4 
24.7 -t 13.X 
15.8 2 7.6 
6.0 ? 3.2 
8.6 + 3.9 
4.x +- 2.2: 
169 2 139 
112 + __- - 175 _. 
137 i- x4 
IX ? 26 
xt: 
I2 2 4 
239 i 143 
337 i I65 
I96 i 102 
95 + 30 
I26 % 53 
I.18 f 0.75 
I.04 i 0.80 
I69 + 5X 
203 + 77 
0.65 ? 0.33 
0.59 % 0.30 
20.5 + l3.6* 52 t 57 I14 ? 93* 
32.9 ir I l.l*t 57 -+ 67 I57 + 105* 
30.7 2 x.x*+ _ 2.35 t 116t: 
30.8 t 16.7” 
46.5 ? l3.0”+ 
44.7 i 11.4+ 
53 t 51 
81 + 98 
_. 
I I? + 79” 
I24 + 85 
?I5 + IIXI 
12.3 + 6.4” 
17.7 t 6.3”: 
15.4 t 6.5” 
51 +54 
40 ? 72 
I09 + 98 
I26 ? 75* 
244 -c 112t’i 
32x i 15x 
422 + 263 
397 i- 174 
47 ? 60 
40 -+ 61 
1x0 t I89 
I12 2 I23 
259 t I52 
x+9 
322 
121 
-34 -c 27 
-34 + 27 
-48 i- 25 
-57 -+ 17 
-120 + 9Y.J 
535 + 332* 64 + 65 I?1 + II9 
71x i 227*+ 49 + 77 139 2 81 
696 i 271 - 288 ? l29t$ 
16X t 72” 35 -+ 23 75 t 35* 
20X + 69” 3x f 22 6X + 35* 
0.6X ? 0.40 -36 ? IO -42 -t I2 
0.65 + 0.65 -35 + II -42 ? I3 
246 ? x5* 29 ? 49 53 + 52 
27X 5 86* 24 I! I3 45 ? 34 
0.43 t 0.17: -30 2 I6 -29 ? 27 
0.39 + O.l6$ -29 ? IO -29 + 22 
*p < 0.05 preceding value: +p <: 0.05 versus before angioplasty: +p < 0.0s versus after angioplasty. C = control: CSF = total coronary sinus flow tmlimin): 
CSR = coronary sinus resistance (MAPICSF): CVR, = coronary vascular resistance index. mean arterial pressure/mean VEL (units); DOP flow = 
Doppler-derived absolute flow (mlimin) based on diastolic velocity integral (DFV, = I,. Fig. I j (cross-sectional area of stenosis *HR): GVF = great cardiac vein 
flow (ml/mm); GVR = great vein resistance (MAPIGVF): mACC = mean acceleration (cm/s per s): mean VEL = mean coronary velocity (cm/s); N = 
intracoronary nitroglycerin. 200 ~g; P = intracoronary papaverine. IO mg; peak VEL = peak maximal velocity (cm/s): %IN,P = [(peak response (N or P) - 
control/control)~lOO) 
reserve ratio mean responses for arterial velocity, venous nonsignificant findings. A polynomial regression analysis, 
flow and normal velocity (papaverine only) responses. applied similarly, demonstrated nonsignificant results. 
Comparison of coronary reserve ratios with angiographic 
measurements. Statistical correlations of coronary reserve 
responses and angiographic measurements yielded a signifi- 
cant correlation for linear regression analysis in only the 
papaverine coronary reserve ratio versus stenosis diameter 
(and area) after angioplasty (r’ = 0.398, F statistic = 6.604, 
p = 0.027) for arterial velocity, but not for coronary vein 
flow responses. Analysis was also performed using the log of 
the area and the log of the stenosis diameter, which revealed 
Discussion 
The purpose of this study was to examine coronary 
vasodilator responses after elimination of major epicardial 
luminal obstruction to identify factors, other than reserve 
ratios, of improved coronary circulatory responses. 
Coronary flow velocity indexes and angioplasty. The three 
major findings of this study are as follows: 1) Coronary 
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Table 6. Coronary Hemodynamic and Reserve Ratio Data Before (Pre) and After (Post) Coronary Angioplasty 
initial COR 
Gradient OP 
(mm (mm 
Hg) Hg) 
Final 
Gradient 
(mm 
Hg) 
Stenosis (70) 
Pre Post 
Coronary Reserve Ratio 
Pre Post 
N, P, NZ Pa Normal (Pt no.) 
Group I 
2 
4 
6 
8 
9* 
10 
I1 
12 
13* 
14 
IS 
16 
17 
Mean IT SD 
Group II 
4 
6 
8 
10 
Mean + SD 
40 28 10 61 21 - 2.63 
64 30 IO 77 4 I .7s 2.67 
48 30 18 19 16 1.32 1.82 
40 2s 20 79 24 1.14 2.27 
60 20 30 82 17 1 .oo 2.14 
45 - 20 73 17 I .oo 2.00 
50 28 20 51 21 2.05 2.68 
65 30 38 73 20 2.27 1.64 
IO 10 90 26 1.25 2.23 
50 28 28 77 26 I .47 1.61 
60 22 35 14 6 0.79 0.56 
45 18 10 58 IO 1.54 2.65 
60 20 20 81 21 - I .oo 
60 24 28 80 35 - 1.68 
40 20 35 67 16 - 5.23 
70 18 35 95 60 1.33 2.02 
- 20 20 99 30 - 1.86 
52 + II 23 A 5 20 + 12 75 ? IO 24 + 22 1.52 ? 0.57 2.14 2 0.93 
40 40 25 82 28 1.21 
50 35 40 73 31 1.25 
- - - 71 9 I .90 
- - 28 82 26 1.16 
25 2s IO 85 20 1.15 
36 31 8 80 24 1.22 
78 30 18 75 37 1.29 
60 24 0 91 12 1.37 
45 35 IO 70 10 1.49 
50 25 IO 65 14 I .46 
48 2 16 31 + 6 17 + 12 68 t 22 22 + 10 1.35 + 0.23 
I .87 - 1.15 
1.55 1.21 1.64 
2.39 1.35 1.63 
1 so 1.56 1.34 
I .49 1.14 1.73 
1.65 1.72 2.13 
1.45 1.35 1.33 
2.00 1.07 1.96 
1.42 1.57 1.70 
2.22 1.41 I .70 
1.05 * 0.35 1.38 * 0.22 1.68 ? 0.351 
- 
1.83 
1.50 
1.40 
1.25 
2.00 
1.01 
1.80 
I .45 
1.43 
0.72 
3.45 
- 
- 
- 
1.64 
- 
1.57 A 0.67 
2.50 
5.33 
2.14 
2.00 
3.88 
4.00 
2.14 
1.79 
I .67 
1.79 
1.05 
2.97 
2.43 
I .98 
3.95 
2.16 
1.77 
2.57 A 1.05 
1.98 (II) 
2.11 (9) 
3.72 
5.37 
2.23 
2.46 
3.97 
3.79 
3.02 
4.25 
5.18 (13) 
3.90 (10) 
1.56 (IO) 
3.96 
3.88 (IS) 
2.15 
3.35 + 1.161 
*p < 0.05 versus group 1; tp < 0.01 versus Pz. COR OP = coronary artery occlusion wedge pressure; coronary reserve ratios = peak/rest flow or velocity 
ratio using intracoronary nitroglycerin (N,. NJ or papaverine (P,, PJ before (1) and after (2) angioplasty: initial gradient, final gradient = aortic-coronary arterial 
pressure gradient before and after angioplasty; SD = standard deviation: Pt no. ( ) = normal segment responses obtained from corresponding patient in Group 
I; stenosis = percent angiographic diameter narrowing of coronary artery: - = data not obtained. All study segments in Group 1 were the left anterior descending 
coronary artery except in Patients 9 and 13 (left circumflex coronary artery). 
reserve ratios based on maximal phasic or mean coronary 
velocity, diastolic flow velocity integrals, great cardiac vein 
flow, Doppler-derived coronary flow or time indexes of 
diastolic coronary flow velocity do not provide consistent 
information regarding the angioplasty result. 2) Postangio- 
plasty absolute values of papaverine hyperemic phasic and 
mean velocity and diastolic flow velocity integral are nearly 
normalized in most patients. 3) Vasodilator responses in 
normal arterial segments in patients undergoing angioplasty 
in another left coronary segment are similar to responses in 
normal subjects and patients without left coronary artery 
disease. 
In experimental animals and in well defined, limited 
groups of patients, several investigators (1,7,8,12,19,32-34) 
demonstrated quantitative determinations of coronary vaso- 
dilatory reserve as a method for assessing the hemodynamic 
significance of coronary stenosis. In the present clinical 
study, the coronary vasodilator reserve ratio before and 
after an intervention assumes that conditions exist to pro- 
duce a normal response without epicardial obstruction. 
However, diffuse and heterogenous atherosclerotic arterial 
disease may be found in a majority of patients undergoing 
angioplasty, and most likely impairs “normal” coronary 
circulatory responses to variable degrees. These findings 
concur with those of Wilson et al. (ll), indicating that a 
diminished coronary reserve capacity persists despite a 
reduction in epicardial coronary resistance after balloon 
luminal enlargement in many patients. This early impairment 
improves in a majority of patients restudied late (average 
7.4 f 1.2 months) after angioplasty. 
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Figure 3. Individual patient coronary velocity reserve ratio re- 
sponses before (Pre) and after (Post) angioplasty for nitroglycerin 
(NTG) and papaverine (PAP) compared with papaverine responses 
in the normal group. Mean values are provided in Figure 4. 
The abnormal reduced coronary vasodilator responses 
before and immediately after angioplasty were present as 
assessed by both absolute and relative flow responses mea- 
sured by coronary artery velocity and vein flow in response 
to maximal and submaximal stimuli, consistent with previ- 
ous reports (9-13). Restoration of coronary reserve ratios 
Figure 4. Comparison of coronary vasodilatory reserve ratio before 
and after coronary angioplasty (PTCA) with responses of arterial 
velocity and cardiac venous flow after nitroglycerin (NTG) and 
papaverine (PAP). The normal responses were significantly greater 
(p < 0.01) than the velocity responses to papaverine (and all other 
values) after angioplasty. 
.9 NTG PAP NTG PAP 
0 before PTCA 
m after PTCA 
>3.5, previously reported (2.32) as the lower limits of normal 
values for intracoronary Doppler mean velocity, occurred in 
only 4 of the 17 patients (Patients 2, 5. 6 and 14) after 
angioplasty. On detailed examination, these four patients had 
no distinguishing clinical (difference in calcium channel or 
beta-receptor blocker therapy), angiographic or technical 
features (duration of balloon inflation, time between infla- 
tions) to explain the “normalized” responses. The postangio- 
plasty percent stenosis (4%, 17%, 17% and 16%, respectively) 
and absolute diameter stenosis (2.50, 2.32, 3.13 and 2.10 mm. 
respectively) in the four patients did not separate their re- 
sponses from those of other patients. Patient 6 did have the 
largest arterial diameter (3.40 mm) of both the proximal 
normal segment and the postangioplasty dilated segment (3.13 
mm). with a 17% residual angiographic diameter narrowing. 
Unlike the patients studied by Wilson et al. (1 I), no patient in 
our study had acute unstable angina before angioplasty or had 
right coronary artery procedures. Two patients with circum- 
flex artery angioplasty were included for velocity measure- 
ments. The comparison of anterior venous efflux and left 
anterior descending artery velocity responses is unchanged 
when the analysis excludes these two patients. 
Abnormal coronary vasodilator mechanisms. Postulated 
mechanisms for impaired coronary vasodilator reserve after 
angioplasty (11) may include a number of factors involved in 
the autoregulatory homeostasis of epicardial and small pre- 
capillary regulatory arterioles (17,35.36). Other contributing 
influences include vascular smooth muscle damage (37,38), 
endothelial vasomotor factor release or inhibition (39-41) or 
local release of circulating factors directly affecting coronary 
vasomotor tone (39,42-44). Platelet activation and release of 
platelet-mediated vasomotor products (44) may also play a 
role. Increased coronary blood flow can independently dilate 
epicardial coronary arteries; this phenomenon is thought to 
occur through flow-mediated endothelium-dependent vaso- 
dilation (41). Endothelial dysfunction is postulated (15) to 
account for the inability of diseased atherosclerotic arterial 
segments to respond appropriately to vasodilator stimula- 
tion. Hypersensitivity of vascular smooth muscle in athero- 
sclerotic plaque has been associated with enhanced vasocon- 
striction (16.42.43.44). 
The coronary vasodilator reserve ratio before and after an 
intervention also assumes comparable control blood flow 
(velocity) at rest and similar production of maximal hypere- 
mic responses before and after the intervention. However. 
blood flow velocity values at rest tended to increase after 
angioplasty, contributing to unimproved vasodilator ratios. 
Whether (transiently) augmented basal coronary flow with 
resetting of autoregulatory mechanisms after angioplasty 
accounts for a diminished maximal intracoronary vasodila- 
tory responses remains speculative. 
Coronary reserve responses and angiographic results. 
Angiographic computations of cross-sectional area in this 
study are only approximate because quantitative digital 
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radiographic methodology (46) was not yet available in our 
laboratory. A symmetric stenosis configuration was as- 
sumed. Correlations with reserve ratios and angiographic 
measurements were poor, reflecting the inherent limitation 
of visual and semiquantitative (caliper) estimations of angio- 
graphic luminal dimensions, a problem that remains an 
unresolved methodologic dilemma in the assessment of 
coronary artery disease (47,48). Although coronary reserve 
ratio correlations improved slightly after angioplasty for 
papaverine hyperemic responses, these findings are similar 
to those of Legrand et al. (49), who also noted the general 
failure of angiography to satisfactorily predict coronary flow 
reserve for significant and physiologically important coro- 
nary lesions. 
Rationale for arterial velocity and cardiac venous flow 
techniques in assessing coronary reserve. Previous studies 
measuring coronary flow were confined to regional coronary 
vein thermodilution efflux (50), radioactive tracer coronary 
washout techniques (51) and digital radiographic blood flow 
analysis (8,12), each subject to unique methodologic limita- 
tions (52). Selective coronary artery velocity measurement 
does not provide absolute flow values, but is a highly reliable 
technique to estimate relative coronary flow changes 
(19,20,52). By assuming a stable vessel cross-sectional area 
at the time of velocity measurement, approximate volumet- 
ric coronary flow values can be derived (26). To provide an 
accepted, although less precise, quantitative correlative 
technique for anterior left ventricular regional coronary 
vasomotor responses, great cardiac vein flow by thermodi- 
lution was also measured. The less sensitive, less dynamic 
measurement capacity of coronary vein flow reserve is 
apparent in the lower ratios computed for Group II (Table 5). 
Although lower coronary reserve ratios were obtained, the 
two techniques appeared to complement and support similar 
conclusions regarding impaired coronary reserve after angio- 
plasty. 
Limitations. Several myocardial and hemodynamic vari- 
ables must be considered as contributors to abnormal coro- 
nary vasodilator reserve responses. Factors such as chang- 
ing distal artery pressure, left ventricular scar, hypertrophy 
or ischemic dysfunction (for example, anterior hypokinesia), 
increased contractility, heart rate, left ventricular end- 
diastolic pressure and altered vascular myogenic tone can 
influence reactive coronary and, possibly, pharmacologic 
hyperemia (18,53). Vasodilator responses in patients with 
anterior hypokinesia may differ from normal, but were 
similar to those of other patients undergoing angioplasty 
with normal left ventricular wall motion. Intracoronary drug- 
or vehicle-related factors such as osmolality, oxygen content 
and chemical composition as well as direct effects on abnor- 
mal endothelial segments have also been reported (54) to 
alter coronary hyperemic responses. Within the limits and 
control of the experimental design, these factors remained 
relatively constant. 
Suboptimal or subselective 
drug administration may result 
intracoronary vasodilator 
in different concentrations 
delivered to the target vessel. Although ranges up to 12 to 14 
mg have been suggested (32), 10 mg of papaverine has been 
used most commonly to achieve maximal vasodilation in 
most studies applying these techniques (10,11,24,34). Atten- 
tion was given to identical catheter positioning and avoid- 
ance of large side branches (>12% major vessel) for place- 
ment of the Doppler catheter before and after angioplasty. 
Stable and reproducible catheter signals are mandatory for 
satisfactory data. We attempted to duplicate catheter posi- 
tion proximal to the angioplasty site and use of signals with 
clearly demarcated phasic wave forms for analysis. 
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Errors in Doppler velocity measurements are related to 
shape of the velocity profile, angle of incidence and position 
of the sample volume proximal to the lesion. Previous 
methodologic studies (19,20) have shown a linear relation 
between velocity and coronary blood flow, as well as a high 
correlation between intracoronary and epicardial Doppler 
velocities. Technical problems influencing the accuracy of 
coronary velocity and coronary sinus thermodilution tech- 
niques have been described in detail elsewhere (19,27). 
Patients with recent prior myocardial infarction (clinically 
or by left ventricular wall motion with more than minimal 
anterior hypokinesia) or significant left ventricular hypertro- 
phy by ECG were excluded. Because of the inherent limita- 
tions of human studies of this type, we did not obtain 
simultaneous arterial and venous flow measurements in the 
same patient, nor did we obtain data >45 min after the 
angioplasty, limiting our conclusions regarding the simulta- 
neous and potentially transient nature of these observations. 
Clinical significance. Although coronary blood flow ve- 
locity measured during angioplasty (55) may predict func- 
tional result and although late improvement in coronary 
velocity reserve ratios may appear months after angioplasty, 
immediate postangioplasty coronary flow velocity indexes 
and ratios are limited quantitative variables for assessing the 
physiologic results of coronary dilation. Although some 
absolute velocity indexes approach normal levels after 
angioplasty, peak hyperemicibasal flow ratios, assessed by 
several different methods, are attenuated relative to normal 
angiographic segments. These findings are important and 
should be considered when assessing coronary vasomotor 
responses in patients with atherosclerotic coronary disease, 
especially after intraarterial manipulations. 
We thank the cardiac catheterization team of the Mudd Laboratory and 
Donna Sander for manuscript preparation. 
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